SMN2 and proximal spinal muscular atrophy: In addition, if the Smn C-T-Neo and/or Smn2B-Neo is used as the Smn mutant background in combination with SMN2 transgenic mice to achieve postnatal survival, new SMA models can potentially be generated with varying degrees of severity.